Showing results (1-10 of 215) with videos related to
Sort By:
Pageof 22
Acta Bio-Medica : Atenei Parmensis|October 1, 2015
Obesity: a key component of psoriasisBernardo Correia, Tiago TorresDrugs|August 4, 2017
Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on RisankizumabTiago TorresClinical Drug Investigation|November 3, 2017
Tofacitinib: A New Oral Therapy for PsoriasisAlexandra Azevedo, Tiago TorresActa Dermatovenerologica Croatica : ADC|September 18, 2014
Psoriasis and metabolic syndromeRita Sales, Tiago TorresDrugs in Context|June 28, 2021
Bimekizumab: the new drug in the biologics armamentarium for psoriasisEgídio Freitas, Tiago TorresDermatology and Therapy|March 3, 2026
High-Dose, Extended Half-Life IL-23 Inhibitors: the Next Big Step in Psoriasis Care?Tiago Torres, Andrew BlauveltAmerican Journal of Clinical Dermatology|March 12, 2026
Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of PsoriasisCésar Ferreira, Tiago TorresThe Journal of International Medical Research|June 30, 2023
Difamilast for the treatment of atopic dermatitisEgídio Freitas, Tiago TorresBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 23, 2018
Guselkumab for the Treatment of PsoriasisÁlvaro Machado, Tiago TorresPageof 22